Clinical Trial Update: Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 study update evaluating brexpiprazole as maintenance therapy for adults with schizophrenia, focusing on efficacy, safety, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Acute Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2017-01-13